| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
35,915,000 |
| Market
Cap: |
4.96(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$36.74 - $136.14 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile TransMedics Group is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across various disease states. Co. has developed the Organ Care System (OCS), a portable organ perfusion and monitoring system that using Co.'s technology to replicate near-physiologic conditions for donor organs outside of the human body. The OCS was designed to perfuse donor organs with warm, oxygenated and nutrient-enriched blood, while maintaining the organs in a living, functioning state; the lung is breathing, the heart is beating and the liver is producing bile. Co.'s OCS products are one for each of lung, heart and liver transplantations.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
2,500 |
2,500 |
| Total Buy Value |
$0 |
$0 |
$155,000 |
$155,000 |
| Total People Bought |
0 |
0 |
1 |
1 |
| Total Buy Transactions |
0 |
0 |
1 |
1 |
| Total Shares Sold |
403,373 |
481,902 |
544,809 |
1,199,398 |
| Total Sell Value |
$43,514,773 |
$49,821,733 |
$54,548,680 |
$91,279,691 |
| Total People Sold |
7 |
8 |
8 |
11 |
| Total Sell Transactions |
27 |
39 |
49 |
128 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Hassanein Waleed H |
President & CEO |
• • – |
2020-03-27 |
4 |
OE |
$0.39 |
$39,000 |
D/D |
100,000 |
215,429 |
|
- |
|
| Carey John F |
VP of Operations |
• – – |
2020-03-02 |
4 |
AS |
$15.13 |
$30,345 |
D/D |
(2,000) |
3,200 |
|
13% |
|
| Carey John F |
VP of Operations |
• – – |
2020-03-02 |
4 |
OE |
$0.39 |
$780 |
D/D |
2,000 |
5,200 |
|
- |
|
| Carey John F |
VP of Operations |
• – – |
2020-02-03 |
4 |
AS |
$17.71 |
$35,420 |
D/D |
(2,000) |
1,200 |
|
-14% |
|
| Carey John F |
VP of Operations |
• – – |
2020-02-03 |
4 |
OE |
$0.39 |
$780 |
D/D |
2,000 |
3,200 |
|
- |
|
| Khayal Tamer I |
Chief Commercial Officer |
• – – |
2020-01-21 |
4 |
AS |
$20.02 |
$100,100 |
D/D |
(5,000) |
46,076 |
|
-21% |
|
| Khayal Tamer I |
Chief Commercial Officer |
• – – |
2020-01-21 |
4 |
OE |
$0.39 |
$1,950 |
D/D |
5,000 |
51,076 |
|
- |
|
| Carey John F |
VP of Operations |
• – – |
2020-01-17 |
4 |
OE |
$0.28 |
$560 |
D/D |
2,000 |
3,200 |
|
- |
|
| Carey John F |
VP of Operations |
• – – |
2020-01-02 |
4 |
AS |
$18.95 |
$37,900 |
D/D |
(2,000) |
1,200 |
|
-10% |
|
| Carey John F |
VP of Operations |
• – – |
2020-01-02 |
4 |
OE |
$0.39 |
$780 |
D/D |
2,000 |
3,200 |
|
- |
|
| Kania Edwin M Jr |
Director |
– • – |
2019-12-12 |
4 |
A |
$0.00 |
$0 |
I/I |
3,873 |
3,873 |
|
- |
|
| Kania Edwin M Jr |
Director |
– • – |
2019-12-12 |
4 |
D |
$0.00 |
$0 |
I/I |
(390,000) |
779,571 |
|
- |
|
| Lung Biotechnology Pbc |
10% Owner |
– – • |
2019-12-09 |
4 |
S |
$18.75 |
$9,375,000 |
I/I |
(500,000) |
2,053,240 |
|
- |
|
| Carey John F |
VP of Operations |
• – – |
2019-11-15 |
4 |
OE |
$0.28 |
$336 |
D/D |
1,200 |
1,200 |
|
- |
|
| Sullivan John F |
VP of Quality & Engineering |
• – – |
2019-11-15 |
4 |
OE |
$0.28 |
$392 |
D/D |
1,400 |
10,828 |
|
- |
|
| Weill David |
Director |
– • – |
2019-11-11 |
4 |
B |
$17.00 |
$170,000 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
| Afeyan Noubar |
10% Owner |
– – • |
2019-10-29 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,840,191) |
0 |
|
- |
|
| Kania Edwin M Jr |
Director |
– • – |
2019-10-29 |
4 |
A |
$0.00 |
$0 |
D/D |
120,595 |
153,928 |
|
- |
|
| Khayal Tamer I |
Chief Commercial Officer |
• – – |
2019-08-09 |
4 |
OE |
$0.28 |
$364 |
D/D |
1,300 |
46,076 |
|
- |
|
| Hassanein Waleed H |
President & CEO |
• • – |
2019-08-09 |
4 |
OE |
$0.28 |
$1,680 |
D/D |
6,000 |
115,429 |
|
- |
|
| Hassanein Waleed H |
President & CEO |
• • – |
2019-06-13 |
4 |
OE |
$0.28 |
$1,120 |
D/D |
4,000 |
109,429 |
|
- |
|
| Lung Biotechnology Pbc |
10% Owner |
– – • |
2019-05-06 |
4 |
A |
$0.00 |
$0 |
I/I |
2,553,240 |
2,553,240 |
|
- |
|
| Gordon Stephen |
Chief Financial Officer |
• – – |
2019-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
28,571 |
28,571 |
|
- |
|
| Gordon Stephen |
Chief Financial Officer |
• – – |
2019-05-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(100,000) |
0 |
|
- |
|
| Khayal Tamer I |
Chief Commercial Officer |
• – – |
2019-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
44,776 |
44,776 |
|
- |
|
350 Records found
|
|
Page 13 of 14 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
3.05 (2.26%) 
